Use of pretreatment metabolic tumour volumes to predict the outcome of pharyngeal cancer treated by definitive radiotherapy (Q58814272)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22532254%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Use of pretreatment metabolic tumour volumes to predict the outcome of pharyngeal cancer treated by definitive radiotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22532254%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22532254%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Chia-Hung Kao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22532254%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Shih-Chieh Lin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22532254%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Kuo-Yang Yen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22532254%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Shih-Neng Yang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22532254%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Yao-Ching Wang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22532254%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Ji-An Liang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22532254%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Chun-Hung Hua

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22532254%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Shang-Wen Chen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22532254%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

25 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22532254%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Nuclear Medicine and Molecular Imaging

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22532254%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22532254%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22532254%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

1297-1305

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22532254%20AND%20SRC:MED&resulttype=core&format=json

Volumetric staging (VS) is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRT.

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

Can FDG PET predict radiation treatment outcome in head and neck cancer? Results of a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

FDG-PET. A possible prognostic factor in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

FDG-PET prediction of head and neck squamous cell cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

Value of fluorodeoxyglucose positron emission tomography before radiotherapy for head and neck cancer: does the standardized uptake value predict treatment outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

18F-FDG PET/CT-based gross tumor volume definition for radiotherapy in head and neck cancer: a correlation study between suitable uptake value threshold and tumor parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: a brief technical report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

Positron emission tomography 18F-fluorodeoxyglucose uptake and prognosis in patients with surgically treated, stage I non-small cell lung cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

Biological correlates of FDG uptake in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

Metabolic tumor burden predicts for disease progression and death in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

Standard uptake value and metabolic tumor volume of ¹⁸F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

Human papillomavirus and survival of patients with oropharyngeal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

The increasing clinical relevance of human papillomavirus type 16 (HPV-16) infection in oropharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

Lower prevalence but favorable survival for human papillomavirus-related squamous cell carcinoma of tonsil in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

New evidence for geographic variation in the role of human papillomavirus in tonsillar carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2127-7

Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.

21 January 2018

1 reference

12 December 2020

Prognostic impact of tumor volume in patients with stage III-IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy

1 reference

12 December 2020

Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia

1 reference

12 December 2020

Rapid rise in FDG uptake in an irradiated human tumour xenograft.

1 reference

12 December 2020

A threshold method to improve standardized uptake value reproducibility

1 reference

12 December 2020

Preradiotherapy computed tomography as a predictor of local control in supraglottic carcinoma

1 reference

12 December 2020

In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck

1 reference

12 December 2020

Understanding the standardized uptake value, its methods, and implications for usage.

1 reference

12 December 2020

10.1007/S00259-012-2127-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22532254%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference